September 19, 2017
Article
Hyman Muss, MD, discusses special considerations that should be taken when treating older patients with HER2-positive or triple-negative breast cancer.
September 17, 2017
Article
HER2-positive breast cancer has gone from "worst to first" because of the success of the monoclonal antibody drug trastuzumab in combination with chemotherapy.
September 16, 2017
Article
Breast cancer in younger women needs a different adjuvant treatment strategy from that used in post-menopausal women, but it may not have to include suppressing ovarian function.
September 16, 2017
Article
Figuring out how a certain genetic result found through multigene testing might change not only the type of intervention but its timing is the chief challenge, according to Mark Robson, MD, in a presentation at the 2017 Lynn Sage Breast Cancer Symposium.
September 15, 2017
Article
Andrew Seidman, MD, discusses the Watson for Oncology application and the potential for Watson to be a valuable partner for oncologists during the 19th Annual Lynn Sage Breast Cancer Symposium.
September 15, 2017
Article
Judith A. Paice, PhD, RN, discusses the best way to approach pain management in breast cancer.